SEP 174559

Drug Profile

SEP 174559

Alternative Names: (S)-desmethylzopiclone; S-desmethylzopiclone; SEP-174559

Latest Information Update: 11 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sepracor
  • Class Anxiolytics
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Muscle spasticity; Spasm

Most Recent Events

  • 22 Aug 2005 This compound is still in active development
  • 10 Oct 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section
  • 19 Sep 2001 Phase-I clinical trials for Anxiety disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top